nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Lamivudine—hepatitis B	0.24	1	CbGbCtD
Zafirlukast—Raised liver function tests—Lamivudine—hepatitis B	0.0159	0.0279	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.0129	0.0225	CcSEcCtD
Zafirlukast—Hepatic failure—Entecavir—hepatitis B	0.0128	0.0225	CcSEcCtD
Zafirlukast—Influenza like illness—Telbivudine—hepatitis B	0.0127	0.0222	CcSEcCtD
Zafirlukast—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.0125	0.0219	CcSEcCtD
Zafirlukast—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.0104	0.0182	CcSEcCtD
Zafirlukast—Throat sore—Lamivudine—hepatitis B	0.0102	0.0179	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.0101	0.0177	CcSEcCtD
Zafirlukast—Neutropenia—Entecavir—hepatitis B	0.00931	0.0163	CcSEcCtD
Zafirlukast—Blood disorder—Lamivudine—hepatitis B	0.0088	0.0154	CcSEcCtD
Zafirlukast—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00844	0.0148	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Lamivudine—hepatitis B	0.00813	0.0142	CcSEcCtD
Zafirlukast—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00813	0.0142	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Lamivudine—hepatitis B	0.00808	0.0142	CcSEcCtD
Zafirlukast—Hepatitis—Entecavir—hepatitis B	0.00797	0.014	CcSEcCtD
Zafirlukast—Abdominal discomfort—Telbivudine—hepatitis B	0.00784	0.0137	CcSEcCtD
Zafirlukast—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00778	0.0136	CcSEcCtD
Zafirlukast—Neutropenia—Telbivudine—hepatitis B	0.00765	0.0134	CcSEcCtD
Zafirlukast—Vasculitis—Lamivudine—hepatitis B	0.00753	0.0132	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Telbivudine—hepatitis B	0.00715	0.0125	CcSEcCtD
Zafirlukast—Neuropathy—Lamivudine—hepatitis B	0.0069	0.0121	CcSEcCtD
Zafirlukast—Back pain—Adefovir Dipivoxil—hepatitis B	0.00655	0.0115	CcSEcCtD
Zafirlukast—Hepatitis—Telbivudine—hepatitis B	0.00655	0.0115	CcSEcCtD
Zafirlukast—Hypoaesthesia—Telbivudine—hepatitis B	0.00651	0.0114	CcSEcCtD
Zafirlukast—Injury—Lamivudine—hepatitis B	0.0058	0.0102	CcSEcCtD
Zafirlukast—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00576	0.0101	CcSEcCtD
Zafirlukast—CYSLTR1—blood—hepatitis B	0.00565	0.093	CbGeAlD
Zafirlukast—Infection—Entecavir—hepatitis B	0.00563	0.00985	CcSEcCtD
Zafirlukast—Back pain—Telbivudine—hepatitis B	0.00551	0.00965	CcSEcCtD
Zafirlukast—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00541	0.00947	CcSEcCtD
Zafirlukast—CYP2C19—blood plasma—hepatitis B	0.00529	0.0872	CbGeAlD
Zafirlukast—Ill-defined disorder—Telbivudine—hepatitis B	0.00529	0.00926	CcSEcCtD
Zafirlukast—Malaise—Telbivudine—hepatitis B	0.00514	0.009	CcSEcCtD
Zafirlukast—Insomnia—Entecavir—hepatitis B	0.00512	0.00897	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00503	0.00881	CcSEcCtD
Zafirlukast—Dyspepsia—Entecavir—hepatitis B	0.00498	0.00873	CcSEcCtD
Zafirlukast—Liver function test abnormal—Lamivudine—hepatitis B	0.00492	0.00862	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Entecavir—hepatitis B	0.00489	0.00856	CcSEcCtD
Zafirlukast—Fatigue—Entecavir—hepatitis B	0.00488	0.00855	CcSEcCtD
Zafirlukast—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00486	0.00852	CcSEcCtD
Zafirlukast—Arthralgia—Telbivudine—hepatitis B	0.00485	0.0085	CcSEcCtD
Zafirlukast—Myalgia—Telbivudine—hepatitis B	0.00485	0.0085	CcSEcCtD
Zafirlukast—Discomfort—Telbivudine—hepatitis B	0.00479	0.0084	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00477	0.00835	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Entecavir—hepatitis B	0.00463	0.00811	CcSEcCtD
Zafirlukast—CYP2C8—blood plasma—hepatitis B	0.00462	0.0761	CbGeAlD
Zafirlukast—Thrombocytopenia—Telbivudine—hepatitis B	0.00455	0.00798	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00452	0.00791	CcSEcCtD
Zafirlukast—Abdominal pain—Entecavir—hepatitis B	0.00448	0.00784	CcSEcCtD
Zafirlukast—Body temperature increased—Entecavir—hepatitis B	0.00448	0.00784	CcSEcCtD
Zafirlukast—Abdominal discomfort—Lamivudine—hepatitis B	0.00442	0.00774	CcSEcCtD
Zafirlukast—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00437	0.00765	CcSEcCtD
Zafirlukast—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00437	0.00765	CcSEcCtD
Zafirlukast—CYP1A2—blood plasma—hepatitis B	0.00432	0.0712	CbGeAlD
Zafirlukast—Neutropenia—Lamivudine—hepatitis B	0.00431	0.00755	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00424	0.00742	CcSEcCtD
Zafirlukast—Insomnia—Telbivudine—hepatitis B	0.00421	0.00737	CcSEcCtD
Zafirlukast—CYP2C9—blood plasma—hepatitis B	0.0041	0.0676	CbGeAlD
Zafirlukast—Dyspepsia—Telbivudine—hepatitis B	0.00409	0.00717	CcSEcCtD
Zafirlukast—Asthenia—Entecavir—hepatitis B	0.00406	0.00711	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Lamivudine—hepatitis B	0.00403	0.00706	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00402	0.00703	CcSEcCtD
Zafirlukast—Fatigue—Telbivudine—hepatitis B	0.00401	0.00702	CcSEcCtD
Zafirlukast—Jaundice—Lamivudine—hepatitis B	0.00401	0.00702	CcSEcCtD
Zafirlukast—Pain—Telbivudine—hepatitis B	0.00398	0.00697	CcSEcCtD
Zafirlukast—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00396	0.00694	CcSEcCtD
Zafirlukast—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00391	0.00685	CcSEcCtD
Zafirlukast—CYP2E1—blood plasma—hepatitis B	0.00389	0.0641	CbGeAlD
Zafirlukast—Diarrhoea—Entecavir—hepatitis B	0.00387	0.00678	CcSEcCtD
Zafirlukast—Sinusitis—Lamivudine—hepatitis B	0.00386	0.00675	CcSEcCtD
Zafirlukast—Agranulocytosis—Lamivudine—hepatitis B	0.00384	0.00672	CcSEcCtD
Zafirlukast—Feeling abnormal—Telbivudine—hepatitis B	0.00383	0.00671	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Telbivudine—hepatitis B	0.0038	0.00666	CcSEcCtD
Zafirlukast—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00378	0.00662	CcSEcCtD
Zafirlukast—PTGS1—blood plasma—hepatitis B	0.00375	0.0617	CbGeAlD
Zafirlukast—Dizziness—Entecavir—hepatitis B	0.00374	0.00656	CcSEcCtD
Zafirlukast—Hepatitis—Lamivudine—hepatitis B	0.00369	0.00646	CcSEcCtD
Zafirlukast—Abdominal pain—Telbivudine—hepatitis B	0.00368	0.00644	CcSEcCtD
Zafirlukast—Body temperature increased—Telbivudine—hepatitis B	0.00368	0.00644	CcSEcCtD
Zafirlukast—Hypoaesthesia—Lamivudine—hepatitis B	0.00367	0.00643	CcSEcCtD
Zafirlukast—Vomiting—Entecavir—hepatitis B	0.0036	0.00631	CcSEcCtD
Zafirlukast—Rash—Entecavir—hepatitis B	0.00357	0.00625	CcSEcCtD
Zafirlukast—Dermatitis—Entecavir—hepatitis B	0.00357	0.00625	CcSEcCtD
Zafirlukast—Headache—Entecavir—hepatitis B	0.00355	0.00621	CcSEcCtD
Zafirlukast—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00351	0.00615	CcSEcCtD
Zafirlukast—Rash—Adefovir Dipivoxil—hepatitis B	0.00348	0.0061	CcSEcCtD
Zafirlukast—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00348	0.00609	CcSEcCtD
Zafirlukast—Headache—Adefovir Dipivoxil—hepatitis B	0.00346	0.00606	CcSEcCtD
Zafirlukast—Nausea—Entecavir—hepatitis B	0.00336	0.00589	CcSEcCtD
Zafirlukast—Asthenia—Telbivudine—hepatitis B	0.00334	0.00584	CcSEcCtD
Zafirlukast—Pruritus—Telbivudine—hepatitis B	0.00329	0.00576	CcSEcCtD
Zafirlukast—Nausea—Adefovir Dipivoxil—hepatitis B	0.00328	0.00575	CcSEcCtD
Zafirlukast—Diarrhoea—Telbivudine—hepatitis B	0.00318	0.00557	CcSEcCtD
Zafirlukast—CYP3A4—blood plasma—hepatitis B	0.00313	0.0516	CbGeAlD
Zafirlukast—Back pain—Lamivudine—hepatitis B	0.00311	0.00544	CcSEcCtD
Zafirlukast—CYP2D6—blood plasma—hepatitis B	0.00308	0.0507	CbGeAlD
Zafirlukast—Dizziness—Telbivudine—hepatitis B	0.00308	0.00539	CcSEcCtD
Zafirlukast—Ill-defined disorder—Lamivudine—hepatitis B	0.00298	0.00522	CcSEcCtD
Zafirlukast—Vomiting—Telbivudine—hepatitis B	0.00296	0.00518	CcSEcCtD
Zafirlukast—Angioedema—Lamivudine—hepatitis B	0.00293	0.00514	CcSEcCtD
Zafirlukast—Rash—Telbivudine—hepatitis B	0.00293	0.00514	CcSEcCtD
Zafirlukast—Dermatitis—Telbivudine—hepatitis B	0.00293	0.00513	CcSEcCtD
Zafirlukast—Headache—Telbivudine—hepatitis B	0.00291	0.0051	CcSEcCtD
Zafirlukast—Malaise—Lamivudine—hepatitis B	0.0029	0.00507	CcSEcCtD
Zafirlukast—Nausea—Telbivudine—hepatitis B	0.00276	0.00484	CcSEcCtD
Zafirlukast—Arthralgia—Lamivudine—hepatitis B	0.00273	0.00479	CcSEcCtD
Zafirlukast—Myalgia—Lamivudine—hepatitis B	0.00273	0.00479	CcSEcCtD
Zafirlukast—Discomfort—Lamivudine—hepatitis B	0.0027	0.00473	CcSEcCtD
Zafirlukast—Oedema—Lamivudine—hepatitis B	0.00262	0.00459	CcSEcCtD
Zafirlukast—Infection—Lamivudine—hepatitis B	0.0026	0.00456	CcSEcCtD
Zafirlukast—Thrombocytopenia—Lamivudine—hepatitis B	0.00257	0.00449	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00239	0.00418	CcSEcCtD
Zafirlukast—Insomnia—Lamivudine—hepatitis B	0.00237	0.00415	CcSEcCtD
Zafirlukast—Dyspepsia—Lamivudine—hepatitis B	0.00231	0.00404	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00226	0.00396	CcSEcCtD
Zafirlukast—Fatigue—Lamivudine—hepatitis B	0.00226	0.00396	CcSEcCtD
Zafirlukast—Pain—Lamivudine—hepatitis B	0.00224	0.00393	CcSEcCtD
Zafirlukast—Feeling abnormal—Lamivudine—hepatitis B	0.00216	0.00378	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Lamivudine—hepatitis B	0.00214	0.00375	CcSEcCtD
Zafirlukast—Urticaria—Lamivudine—hepatitis B	0.00208	0.00365	CcSEcCtD
Zafirlukast—Body temperature increased—Lamivudine—hepatitis B	0.00207	0.00363	CcSEcCtD
Zafirlukast—Abdominal pain—Lamivudine—hepatitis B	0.00207	0.00363	CcSEcCtD
Zafirlukast—CYP2C19—blood—hepatitis B	0.00194	0.032	CbGeAlD
Zafirlukast—Hypersensitivity—Lamivudine—hepatitis B	0.00193	0.00338	CcSEcCtD
Zafirlukast—Asthenia—Lamivudine—hepatitis B	0.00188	0.00329	CcSEcCtD
Zafirlukast—Pruritus—Lamivudine—hepatitis B	0.00185	0.00325	CcSEcCtD
Zafirlukast—Diarrhoea—Lamivudine—hepatitis B	0.00179	0.00314	CcSEcCtD
Zafirlukast—Dizziness—Lamivudine—hepatitis B	0.00173	0.00304	CcSEcCtD
Zafirlukast—CYP2C8—blood—hepatitis B	0.00169	0.0279	CbGeAlD
Zafirlukast—Vomiting—Lamivudine—hepatitis B	0.00167	0.00292	CcSEcCtD
Zafirlukast—Rash—Lamivudine—hepatitis B	0.00165	0.00289	CcSEcCtD
Zafirlukast—Dermatitis—Lamivudine—hepatitis B	0.00165	0.00289	CcSEcCtD
Zafirlukast—ABCG2—blood—hepatitis B	0.00165	0.0271	CbGeAlD
Zafirlukast—Headache—Lamivudine—hepatitis B	0.00164	0.00288	CcSEcCtD
Zafirlukast—CYP1A2—blood—hepatitis B	0.00158	0.0261	CbGeAlD
Zafirlukast—Nausea—Lamivudine—hepatitis B	0.00156	0.00273	CcSEcCtD
Zafirlukast—CYP2C19—liver—hepatitis B	0.00152	0.025	CbGeAlD
Zafirlukast—CYP2C9—blood—hepatitis B	0.0015	0.0248	CbGeAlD
Zafirlukast—CYP2E1—blood—hepatitis B	0.00142	0.0235	CbGeAlD
Zafirlukast—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.00141	0.011	CbGpPWpGaD
Zafirlukast—PTGS1—blood—hepatitis B	0.00137	0.0226	CbGeAlD
Zafirlukast—CYP2C8—liver—hepatitis B	0.00132	0.0218	CbGeAlD
Zafirlukast—ABCG2—liver—hepatitis B	0.00129	0.0212	CbGeAlD
Zafirlukast—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.00126	0.00984	CbGpPWpGaD
Zafirlukast—CYP1A2—liver—hepatitis B	0.00124	0.0204	CbGeAlD
Zafirlukast—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00121	0.00946	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.00119	0.00933	CbGpPWpGaD
Zafirlukast—CYP2C9—liver—hepatitis B	0.00118	0.0194	CbGeAlD
Zafirlukast—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00116	0.00908	CbGpPWpGaD
Zafirlukast—CYP3A4—blood—hepatitis B	0.00115	0.0189	CbGeAlD
Zafirlukast—CYP2D6—blood—hepatitis B	0.00113	0.0186	CbGeAlD
Zafirlukast—CYP2E1—liver—hepatitis B	0.00111	0.0184	CbGeAlD
Zafirlukast—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00111	0.00867	CbGpPWpGaD
Zafirlukast—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.00105	0.00821	CbGpPWpGaD
Zafirlukast—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00102	0.008	CbGpPWpGaD
Zafirlukast—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00101	0.0079	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—F2—hepatitis B	0.00101	0.00786	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.001	0.00782	CbGpPWpGaD
Zafirlukast—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000971	0.00759	CbGpPWpGaD
Zafirlukast—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000943	0.00737	CbGpPWpGaD
Zafirlukast—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000934	0.0073	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000906	0.00708	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000899	0.00703	CbGpPWpGaD
Zafirlukast—CYP3A4—liver—hepatitis B	0.000896	0.0148	CbGeAlD
Zafirlukast—CYP2D6—liver—hepatitis B	0.000882	0.0145	CbGeAlD
Zafirlukast—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000869	0.0068	CbGpPWpGaD
Zafirlukast—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000858	0.00671	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—GGT2—hepatitis B	0.000827	0.00646	CbGpPWpGaD
Zafirlukast—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00079	0.00618	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000776	0.00607	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CXCL10—hepatitis B	0.000762	0.00596	CbGpPWpGaD
Zafirlukast—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000751	0.00587	CbGpPWpGaD
Zafirlukast—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000741	0.0058	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.000716	0.0056	CbGpPWpGaD
Zafirlukast—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000705	0.00551	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—F2—hepatitis B	0.000697	0.00545	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000694	0.00542	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000679	0.00531	CbGpPWpGaD
Zafirlukast—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000671	0.00524	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.000668	0.00523	CbGpPWpGaD
Zafirlukast—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000667	0.00521	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000666	0.00521	CbGpPWpGaD
Zafirlukast—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000662	0.00517	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000635	0.00497	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000635	0.00496	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000628	0.00491	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000623	0.00487	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—GGT2—hepatitis B	0.000618	0.00483	CbGpPWpGaD
Zafirlukast—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000617	0.00482	CbGpPWpGaD
Zafirlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000611	0.00478	CbGpPWpGaD
Zafirlukast—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000609	0.00476	CbGpPWpGaD
Zafirlukast—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000609	0.00476	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000606	0.00474	CbGpPWpGaD
Zafirlukast—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000603	0.00472	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—CCR5—hepatitis B	0.000591	0.00462	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SAG—hepatitis B	0.000585	0.00458	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—RIT2—hepatitis B	0.000585	0.00458	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.000578	0.00452	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000554	0.00433	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000552	0.00432	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000549	0.00429	CbGpPWpGaD
Zafirlukast—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000544	0.00425	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000538	0.00421	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000534	0.00417	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CXCL10—hepatitis B	0.000528	0.00413	CbGpPWpGaD
Zafirlukast—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000522	0.00408	CbGpPWpGaD
Zafirlukast—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000516	0.00403	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—F2—hepatitis B	0.000507	0.00396	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.000501	0.00392	CbGpPWpGaD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.0005	0.00391	CbGpPWpGaD
Zafirlukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000496	0.00388	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.00049	0.00383	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000477	0.00373	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000472	0.00369	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000462	0.00361	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000451	0.00353	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000447	0.0035	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000438	0.00343	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000435	0.0034	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CXCL10—hepatitis B	0.000431	0.00337	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.000428	0.00335	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000424	0.00331	CbGpPWpGaD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TP53—hepatitis B	0.000422	0.0033	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCR5—hepatitis B	0.00041	0.0032	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SAG—hepatitis B	0.000406	0.00317	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RIT2—hepatitis B	0.000406	0.00317	CbGpPWpGaD
Zafirlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000403	0.00315	CbGpPWpGaD
Zafirlukast—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000398	0.00311	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL10—hepatitis B	0.000391	0.00306	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—GGT1—hepatitis B	0.000391	0.00306	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000382	0.00299	CbGpPWpGaD
Zafirlukast—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000378	0.00296	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—CYP2A6—hepatitis B	0.000374	0.00293	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.000371	0.0029	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000356	0.00278	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.000355	0.00278	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—F2—hepatitis B	0.000351	0.00275	CbGpPWpGaD
Zafirlukast—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000348	0.00272	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR5—hepatitis B	0.000334	0.00261	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000331	0.00259	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000327	0.00256	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.000324	0.00254	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000324	0.00253	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR5—hepatitis B	0.000303	0.00237	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.0003	0.00235	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL10—hepatitis B	0.000299	0.00233	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000295	0.00231	CbGpPWpGaD
Zafirlukast—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000295	0.0023	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—GGT1—hepatitis B	0.000292	0.00228	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000289	0.00226	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000287	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—F2—hepatitis B	0.000287	0.00224	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL10—hepatitis B	0.000271	0.00212	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.00027	0.00211	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000266	0.00208	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000263	0.00206	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—F2—hepatitis B	0.00026	0.00203	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000253	0.00197	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000247	0.00193	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000245	0.00191	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR5—hepatitis B	0.000232	0.00181	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL10—hepatitis B	0.000231	0.00181	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000225	0.00176	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000225	0.00176	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000218	0.0017	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000214	0.00167	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR5—hepatitis B	0.00021	0.00164	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.00021	0.00164	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000207	0.00162	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000206	0.00161	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000205	0.0016	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000204	0.00159	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—F2—hepatitis B	0.000199	0.00155	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—hepatitis B	0.000193	0.00151	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000191	0.00149	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—F2—hepatitis B	0.00018	0.00141	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR5—hepatitis B	0.000179	0.0014	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000176	0.00137	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—hepatitis B	0.000175	0.00137	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000174	0.00136	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000174	0.00136	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00017	0.00133	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000169	0.00132	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL10—hepatitis B	0.00016	0.00125	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000158	0.00124	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000158	0.00124	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—F2—hepatitis B	0.000154	0.0012	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKR1B1—hepatitis B	0.000153	0.0012	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00015	0.00117	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000149	0.00116	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKR1B1—hepatitis B	0.000147	0.00115	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GGT2—hepatitis B	0.000147	0.00115	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GGT2—hepatitis B	0.000141	0.00111	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000136	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—hepatitis B	0.000134	0.00105	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR5—hepatitis B	0.000124	0.000971	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—hepatitis B	0.000121	0.00095	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKR1B1—hepatitis B	0.00011	0.000862	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—F2—hepatitis B	0.000107	0.000833	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GGT2—hepatitis B	0.000106	0.000826	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—hepatitis B	0.000104	0.000809	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—hepatitis B	0.000103	0.000805	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CTNNB1—hepatitis B	9.99e-05	0.000781	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CDKN1A—hepatitis B	9.76e-05	0.000763	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTEN—hepatitis B	9.74e-05	0.000762	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.7e-05	0.000758	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NFKB1—hepatitis B	9.69e-05	0.000758	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKR1B1—hepatitis B	9.52e-05	0.000745	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GGT2—hepatitis B	9.13e-05	0.000714	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP2A6—hepatitis B	8.91e-05	0.000697	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.66e-05	0.000677	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP2A6—hepatitis B	8.56e-05	0.00067	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKR1B1—hepatitis B	8.5e-05	0.000665	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GGT2—hepatitis B	8.15e-05	0.000637	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—hepatitis B	8.07e-05	0.000631	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GOT2—hepatitis B	8.06e-05	0.00063	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.99e-05	0.000624	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	7.9e-05	0.000618	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.89e-05	0.000617	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKR1B1—hepatitis B	7.82e-05	0.000611	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKR1B1—hepatitis B	7.75e-05	0.000606	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GOT2—hepatitis B	7.75e-05	0.000606	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GGT2—hepatitis B	7.5e-05	0.000586	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GGT2—hepatitis B	7.43e-05	0.000581	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—hepatitis B	7.18e-05	0.000561	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—hepatitis B	7.14e-05	0.000558	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GGT1—hepatitis B	6.96e-05	0.000544	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GOT1—hepatitis B	6.96e-05	0.000544	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—hepatitis B	6.93e-05	0.000542	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1A—hepatitis B	6.77e-05	0.000529	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—hepatitis B	6.75e-05	0.000528	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.74e-05	0.000527	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NFKB1—hepatitis B	6.72e-05	0.000525	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GOT1—hepatitis B	6.69e-05	0.000523	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GGT1—hepatitis B	6.69e-05	0.000523	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—hepatitis B	6.65e-05	0.00052	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKR1B1—hepatitis B	6.62e-05	0.000518	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP2A6—hepatitis B	6.4e-05	0.0005	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GGT2—hepatitis B	6.35e-05	0.000497	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.09e-05	0.000476	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—hepatitis B	6.08e-05	0.000476	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GOT2—hepatitis B	5.79e-05	0.000453	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—hepatitis B	5.6e-05	0.000438	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP2A6—hepatitis B	5.53e-05	0.000433	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.16e-05	0.000403	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.11e-05	0.0004	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GOT2—hepatitis B	5e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GGT1—hepatitis B	5e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GOT1—hepatitis B	5e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP2A6—hepatitis B	4.94e-05	0.000386	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GGT2—hepatitis B	4.9e-05	0.000383	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—hepatitis B	4.61e-05	0.00036	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.6e-05	0.00036	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP2A6—hepatitis B	4.54e-05	0.000355	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2A6—hepatitis B	4.5e-05	0.000352	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GOT2—hepatitis B	4.47e-05	0.000349	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GOT1—hepatitis B	4.32e-05	0.000338	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GGT1—hepatitis B	4.32e-05	0.000338	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—hepatitis B	4.22e-05	0.00033	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.2e-05	0.000328	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GOT2—hepatitis B	4.11e-05	0.000321	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GOT2—hepatitis B	4.07e-05	0.000318	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.94e-05	0.000308	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GGT1—hepatitis B	3.86e-05	0.000301	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GOT1—hepatitis B	3.86e-05	0.000301	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2A6—hepatitis B	3.85e-05	0.000301	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—hepatitis B	3.7e-05	0.000289	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.59e-05	0.00028	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—hepatitis B	3.56e-05	0.000278	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GOT1—hepatitis B	3.55e-05	0.000277	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GGT1—hepatitis B	3.55e-05	0.000277	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GGT1—hepatitis B	3.52e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GOT1—hepatitis B	3.52e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.51e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GOT2—hepatitis B	3.48e-05	0.000272	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.2e-05	0.00025	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GGT1—hepatitis B	3e-05	0.000235	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GOT1—hepatitis B	3e-05	0.000235	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.97e-05	0.000232	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—hepatitis B	2.82e-05	0.000221	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.74e-05	0.000214	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—hepatitis B	2.71e-05	0.000212	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GOT2—hepatitis B	2.69e-05	0.00021	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—hepatitis B	2.66e-05	0.000208	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GGT1—hepatitis B	2.32e-05	0.000181	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GOT1—hepatitis B	2.32e-05	0.000181	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—hepatitis B	2.3e-05	0.00018	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—hepatitis B	2.05e-05	0.00016	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—hepatitis B	2.03e-05	0.000159	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—hepatitis B	1.89e-05	0.000147	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—hepatitis B	1.87e-05	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—hepatitis B	1.75e-05	0.000137	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—hepatitis B	1.6e-05	0.000125	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—hepatitis B	1.56e-05	0.000122	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—hepatitis B	1.44e-05	0.000113	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—hepatitis B	1.43e-05	0.000112	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—hepatitis B	1.23e-05	9.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—hepatitis B	1.22e-05	9.53e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—hepatitis B	9.41e-06	7.36e-05	CbGpPWpGaD
